Review - Strongyloidiasis: A multifaceted disease

Gastroenterology and Hepatology

Volumn 7, Issue 3, 2011, Pages 194-196

  Ganesh, Swaytha ^a   Cruz Jr , Ruy J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; IMMUNOGLOBULIN E; IVERMECTIN; TIABENDAZOLE;

ABDOMINAL PAIN; ANEMIA; ANOREXIA; ANTIMICROBIAL THERAPY; CONSTIPATION; COUGHING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DUODENUM BIOPSY; DUODENUM OBSTRUCTION; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FALSE POSITIVE RESULT; FECES ANALYSIS; FLATULENCE; FLUORESCENT TREPONEMA ANTIBODY TEST; GASTROINTESTINAL HEMORRHAGE; HEMAGGLUTINATION TEST; HEMOPTYSIS; HUMAN; HYPERINFECTION SYNDROME; HYPOALBUMINEMIA; HYPOCHOLESTEROLEMIA; IMMUNOGLOBULIN BLOOD LEVEL; INAPPROPRIATE VASOPRESSIN SECRETION; INFECTION RISK; INTESTINE OBSTRUCTION; LARVA; LOEFFLER PNEUMONIA; MALABSORPTION; NEMATODE LIFE CYCLE STAGE; NONHUMAN; NOTE; PARALYTIC ILEUS; PARASITE DEVELOPMENT; PARASITE IDENTIFICATION; PARASITE MIGRATION; PLEURA EFFUSION; PLEURAL PAIN; RISK FACTOR; STRONGYLOIDES; STRONGYLOIDES FULLEBORNI; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; WHEEZING;

EID: 79954552627     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (28)

1. Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother. 2007;41:1992-2001. (Pubitemid 350230567)
2. Strongyloidiasis. DPDx: Laboratory Identification of Parasites of Public Health Concern. Available at: http://www.dpd.cdc.gov/dpdx/HTML/Strongyloidiasis. htm.
3. Olsen A, van Lieshout L, Marti H, et al. Strongyloidiasis: the most neglected of the neglected tropical diseases? Trans R Soc Trop Med Hyg. 2009;103:967-972.
4. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis. 1989;11:755-767.
5. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis. 2001;33:1040-1047. (Pubitemid 32907108)
6. Mahmoud AA. Strongyloidiasis. Clin Infect Dis. 1996;23:949-952.
7. Concha R, Harrington W, Rogers AI. Intestinal strongyloidiasis: recognition, management, and determinants of outcomes. J Clin Gastroenterol. 2005;39: 203-211.
8. Yoshida H, Endo H, Tanaka S, Ishikawa A, Kondo H, Nakamura T. Recurrent paralytic ileus associated with strongyloidiasis in a patient with systemic lupus erythematosus. Mod Rheumatol. 2006;16:44-47.
9. Galimberti R, Pontón A, Zaputovich FA, et al. Disseminated strongyloidiasis in immunocompromised patients - report of three cases. Int J Dermatol. 2009;48:975-978.
10. Khanna S, Sedlack RE, Mangan TF. An unusual case of SIADH. Gastroenterol Hepatol (N Y). 2011;7:191-193.
11. Reddy TS, Myers JW. Syndrome of inappropriate secretion of antidiuretic hormone and nonpalpable purpura in a woman with Strongyloides stercoralis hyperinfection. Am J Med Sci. 2003;325:288-291. (Pubitemid 36576367)
12. Sect RC, Gong LL, Tambyath PA. Strongyloides stercoralis hyperinfection and syndrome of inappropriate secretion of antidiuretic hormone. Gastroenterology. 2005;128:8, 252.
13. Hayashi E, Ohta N, Yamamoto H. Syndrome of inappropriate secretion of antidiuretic hormone associated with strongyloidiasis. Southeast Asian J Trop Med Public Health. 2007;38:239-246.
14. Vandebosch S, Mana F, Goossens A, Urbain D. Strongyloides stercoralis infection associated with repititive bacterial meningitis and SIADH: a case report. Acta Gastroenterol Belg. 2008;71:413-417.
15. James CA, Abadie SH. Studies in human Strongyloides II. A comparison of the efficiency of diagnosis by examination of feces and duodenal fluid. Am J Clin Pathol. 1954;24:1154-1158.
16. Lim S, Katz K, Krajden S, Fuksa M, Keystone JS, Kain KC. Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ. 2004;171:479-484. (Pubitemid 39179611)
17. Kishimoto K, Hokama A, Hirata T, et at. Endoscopic and histopathological study on the duodenum of Strongyloides stercoralis hyperinfection. World J Gastroenterol. 2008;14:1768-1773. (Pubitemid 351493383)
18. Thompson BF, Fry LC, Wells CD, et al. The spectrum of GI strongyloidiasis: an endoscopic-pathologic study. Gastrointest Endosc. 2004;59:906-910.
19. Ramdial PK, Hlatshwayo NH, Singh B. Strongyloides stercoralis mesenteric lymphadenopathy: clue to the etiopathogenesis of intestinal pseudo-obstruction in HIV-infected patients. Ann Diagn Pathol. 2006;10:209-214. (Pubitemid 44056238)
20. Lindo JF, Conway DJ, Atkins NS, Bianco AE, Robinson RD, Bundy DA. Prospective evaluation of enzyme-linked immunosorbent assay and immunoblot methods for the diagnosis of endemic Strongyloides stercoralis infection. Am J Trop Med Hyg. 1994;51:175-179. (Pubitemid 24324738)
21. Louisy CL, Barton CJ. The radiological diagnosis of Strongyloides stercoralis enteritis. Radiology. 1971;98:535-541.
22. Cruz RJ Jr, Vincenzi R, Ketzer BM. Duodenal obstruction - an unusual presentation of Strongyloides stercoralis enteritis: a case report. World J Emerg Surg. 2010;5:23.
23. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg. 1994;88:344-345. (Pubitemid 24206464)
24. Tarr PE, Miele PS, Peregoy KS, Smith MA, Neva FA, Lucey DR. Case report: rectal administration of ivermectin to a patient with Strongyloides hyperinfection syndrome. Am J Trop Med Hyg. 2003;68:453-455. (Pubitemid 38230646)
25. Boken DJ, Leoni PA, Preheim LC. Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum. Clin Infect Dis. 1993;16:123-126. (Pubitemid 23007241)
26. Lichtenberger P, Rosa-Cunha I, Morris M, et al. Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin. Transpl Infect Dis. 2009;11:137-142.
27. Grein JD, Mathisen GE, Donovan S, Fleckenstein L. Serum ivermectin levels after enteral and subcutaneous administration for Strongyloides hyperinfection: a case report. Scand J Infect Dis. 2010;42:234-236.
28. Chiodini PL, Reid AJ, Wiselka MJ, Firmin R, Foweraker J. Parenteral ivermectin in Strongyloides hyperinfection. Lancet. 2000;355:43-44. (Pubitemid 30072187)